Cargando…

Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection

BACKGROUND: The aim of this study was to determine whether circulating tumor cells (CTCs) have utility as a prognostic biomarker in stage II colorectal cancer (CRC), as well as a biomarker for the selection of patients for adjuvant chemotherapy. METHODS: CTCs were detected in peripheral blood sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jun-Hui, Wang, Dong, Jin, Lan, Wang, Jin, Zhao, Xiao-Mu, Wu, Guo-Cong, Yao, Hong-Wei, Yang, Ying-Chi, Zhang, Zhong-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798397/ https://www.ncbi.nlm.nih.gov/pubmed/35117496 http://dx.doi.org/10.21037/tcr.2020.01.37

Ejemplares similares

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients
por: Yang, Ying-Chi, et al.
Publicado: (2018)

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
por: Kawamura, Junichiro, et al.
Publicado: (2018)

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
por: Hadano, Naoto, et al.
Publicado: (2016)

Survival after curative resection for stage I colorectal mucinous adenocarcinoma
por: Huang, Liang, et al.
Publicado: (2022)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
por: Tie, Jeanne, et al.
Publicado: (2021)

Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer
por: Moyes, L H, et al.
Publicado: (2009)

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer
por: Guthrie, G J K, et al.
Publicado: (2013)

Prognostic significance of high triglyceride and apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery
por: Chen, Xiu-Qing, et al.
Publicado: (2020)

Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma
por: Wang, Li-yu, et al.
Publicado: (2017)

Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis
por: Martinović, Željko, et al.
Publicado: (2016)

Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancer
por: Kim, Jee Yeon, et al.
Publicado: (2017)

Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases
por: Reinert, Thomas, et al.
Publicado: (2022)

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
por: Zhu, Lizhen, et al.
Publicado: (2016)

Leiomyosarcoma of the inferior vena cava level II involvement: curative resection and reconstruction of renal veins
por: Wang, Quan, et al.
Publicado: (2012)

The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer
por: Richards, C H, et al.
Publicado: (2010)

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2021)

Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection
por: Miyoshi, N, et al.
Publicado: (2016)

Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
por: Xu, Yuyan, et al.
Publicado: (2023)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

Circulating miR-449a predicts survival outcome for colorectal cancer following curative resection: An observational study
por: Fu, Dengke, et al.
Publicado: (2021)

The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer
por: Canna, K, et al.
Publicado: (2005)

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection
por: Deng, Yuxiang, et al.
Publicado: (2018)

Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study
por: Chan, Joseph Chung Yan, et al.
Publicado: (2019)

Evaluation of the patients with colorectal cancer undergoing emergent curative surgery
por: Kundes, Fikri, et al.
Publicado: (2016)

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I–III colorectal cancer
por: Mima, Kosuke, et al.
Publicado: (2020)

Utility of circulating tumor DNA in patients undergoing hepatectomy for colorectal liver metastases
por: Cnockaert, Philippine, et al.
Publicado: (2023)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection
por: Wang, Jing-Houng, et al.
Publicado: (2021)

Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection
por: Zhang, Yong, et al.
Publicado: (2019)

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection
por: Saso, Kazuhiro, et al.
Publicado: (2019)

Cutoff Values of Preoperative s-CEA Levels for Predicting Survivals after Curative Resection of Colorectal Cancer
por: Park, In Ja, et al.
Publicado: (2005)

Development and validation of a nomogram to predict survival after curative resection of nonmetastatic colorectal cancer
por: Hong, Tingting, et al.
Publicado: (2020)

Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2015)

Early recurrence in patients undergoing curative resection of colorectal liver oligometastases: identification of its clinical characteristics, risk factors, and prognosis
por: Lin, Junzhong, et al.
Publicado: (2017)

Influence of primary tumour and patient factors on survival in patients undergoing curative resection and treatment for liver metastases from colorectal cancer
por: Scherman, P., et al.
Publicado: (2019)

Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis
por: Sugimoto, Atsushi, et al.
Publicado: (2023)

The Prognosis and Recurrence Pattern of Right- and Left-Sided Colon Cancer in Stage II, Stage III, and Liver Metastasis After Curative Resection
por: Nakamura, Yasuyuki, et al.
Publicado: (2021)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rl0vg97ukt8a7p6orfcjegdlcd